NeoMed Inc
NeoMed Inc
NeoMed offers the complete enteral solution from breast to baby. NeoMed was the Innovator of the first comprehensive Enteral Safety System to comply with recommendations set forth by the Joint Commission, FDA, ASPEN, and AAMI. NeoMed advocates the use of sterile products and aseptic technique to deliver the healing breast milk that premature babies require. NeoMed enteral delivery products are designed to be incompatible with Luer or IV devices to reduce the risk of misconnection errors. Reducing necrotizing enterocolitis (NEC) and gut disease, increasing the availability of human breast milk, and increasing the shelf life of available HBM is the driving force behind NeoMed’s evolution of Enteral Nutrition Delivery Systems.

NeoMed is a market leader in the neonatal enteral market servicing over 40% of all NICU beds in the US with elements of our product line.



Latest News



NeoMed's ENFit™ Gains Acceptance from GEDSA.

NeoMed is proud to announce that our “low dose” ENFit™ syringe design solution has gained the acceptance of the industry group (GEDSA) and is expected to become the “global solution” that resolves those concerns regarding low volume medication dosing accuracy. NeoMed’s experience designing innovative delivery devices for Pharmacy, NICU and PICU led to syringe tip design modifications that address volume delivery variances raised with the original ENFit™ dimensional specifications.


Industry support for this “low dose” design is evidenced by the statement below: “The clinical community has voiced its concerns regarding the potential impact the current design may have with respect to low dose administration of medication. In response to these issues, GEDSA has identified a solution that it believes will eliminate the risk of improper dosing. The specifications of, and access to the intellectual property rights to this design have been provided to GEDSA’s members.” Learn More »



NeoConnect receives FDA 510(k) clearance.



Click here for the press release.
How NICU Syringe Choice Can Reduce Fat Loss in Human Breast Milk
Meets ISMP Recommendations
How will the new ISO 80369-3 standard impact you?